Scandinavian Real Heart AB (Publ) (STO:HEART)
Sweden · Delayed Price · Currency is SEK 17.20
+0.05 (0.29%)
Aug 26, 2025, 5:13 PM CET
Scandinavian Real Heart AB (Publ) Company Description
Scandinavian Real Heart AB (Publ) engages in the design and development of an artificial heart.
The company develops Realheart TAH to treat advanced stage heart failure. It also develops RealVAD for pulsating left ventricle assist; PulsePump, a pulsating flow for heart and lung machines; and Sternal Prosthesis to fix the sternum after open-chest surgery.
The company was founded in 1999 and is based in Västerås, Sweden.
Scandinavian Real Heart AB (Publ)
| Country | Sweden |
| Founded | 1999 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 12 |
| CEO | Ina Perkins |
Contact Details
Address: Kopparbergsvägen 6 Västerås, 722 13 Sweden | |
| Website | realheart.se |
Stock Details
| Ticker Symbol | HEART |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0006256798 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Dr. Ina Laura Perkins | MD and Chief Executive Officer |
| Dr. Azad Najar | Founder, Chief Innovation Officer, Head of Product Development and Innovation and Director |
| Magnus Ohman | Director |
| Jimmy Nybom | Interim Chief Financial Officer |
| Thomas Finocchiaro | Chief Technology Officer |
| Dr. Ulf Kjellman | Chief Medical Officer and Member of Medical Advisory Board |